Back
Science

Supervised exercise during pregnancy linked to lower infant BMI at 12 months

View source

A randomized clinical trial published in Frontiers in Global Women's Health investigated the effects of a supervised exercise program during pregnancy on infant body mass index (BMI) and growth trajectories in the first year of life.

Study Overview

126 mother-infant pairs were enrolled in this clinical trial. Pregnant women were randomized between weeks 8–10 of gestation into two groups:

  • Intervention group: Participated in supervised exercise sessions three times per week (60 minutes per session), including aerobic, strength, balance, stretching, and pelvic floor exercises.
  • Control group: Received standard care and educational materials.

Infant measurements (weight, length, BMI, and feeding type) were taken at 1, 2, 4, 6, and 12 months postpartum.

Key Findings

  • Infants in the intervention group had significantly lower BMI at 12 months compared to controls.
  • Infants in the control group had higher odds of being classified as overweight at 4 months, a trend that persisted through 12 months.
  • Mothers in the intervention group gained less weight during pregnancy and had higher rates of exclusive breastfeeding in early infancy.

Why this matters: These findings suggest that structured physical activity during pregnancy may positively influence infant growth patterns and breastfeeding rates, with potential long-term benefits for child health.

Limitations

  1. This was a secondary per-protocol analysis — infant BMI was not the original primary endpoint.
  2. Substantial participant attrition occurred during follow-up.
  3. The study enrolled mainly healthy pregnant women without major complications, which limits generalizability.
  4. Environmental factors such as complementary feeding and family lifestyle were not assessed.
  5. Longer-term effects beyond 12 months remain unknown.

Bottom line: While the results are promising, the study's design and limitations mean these findings should be interpreted with caution until confirmed by larger, longer-term trials.